STOCK TITAN

Bunge Global SA SEC Filings

BG NYSE

Welcome to our dedicated page for Bunge Global SA SEC filings (Ticker: BG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Bunge Global SA filings document the regulatory record of a Swiss-incorporated agribusiness company with registered shares listed on the New York Stock Exchange under BG. Its disclosures cover operating and financial results, material events, proxy governance, shareholder voting matters and capital-structure changes.

The company's recent 8-K filings include amendments to a trade receivables securitization program, executive compensation arrangements tied to integration efforts, amendments to its Articles of Association following share cancellations, and exhibits for results releases. Proxy materials address board governance, voting matters, executive compensation and other shareholder disclosures, while material-event reports also document integration and risk-related information following completed acquisitions.

Rhea-AI Summary

Christos Dimopoulos, Executive VP, Global Markets at Bunge Global SA (BG), acquired 240 restricted stock units on 09/02/2025. The Form 4 shows the grant was recorded at a price of $82.44 and is described as restricted stock units issued pursuant to a dividend feature under the registrant's long-term incentive plans. Following the reported transaction, the filing lists 124,536.808 shares as the amount of common stock beneficially owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Bunge Global SA director Christopher Mahoney received restricted stock units (RSUs) that settled on 09/02/2025 under the company’s long-term incentive plans. The filing reports these RSUs were acquired pursuant to a dividend feature of those plans and shows a post-transaction beneficial ownership of 7,182 shares held directly. The transaction is recorded with a price reference of $82.44. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person and identifies the reporter as a director of Bunge Global SA (ticker BG).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Bunge Global SA director and Chief Executive Officer Gregory A. Heckman reported a Section 16 filing showing he acquired 1,403 restricted stock units on 09/02/2025 under the company's long-term incentive plans via a dividend feature, at an indicated price of $82.44 per share. After the grant, Mr. Heckman beneficially owns 278,033 shares directly and 574,594 shares indirectly through the Gregory A. Heckman Revocable Trust. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Kellie Sears, Chief Human Resources Officer of Bunge Global SA, acquired restricted stock units that converted into 152 shares of Common Stock on 09/02/2025 at an attributed price of $82.44 per share, resulting in 25,397 shares owned directly after the transaction. The filing states these were restricted stock units received pursuant to a dividend feature under the company's long-term incentive plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Carol M. Browner, a director of Bunge Global SA (BG), acquired restricted stock units on September 2, 2025. The Form 4 reports the RSUs were received pursuant to a dividend feature under the company's long-term incentive plans. Following the reported transaction, the filing shows 29,566 shares beneficially owned. The disclosure lists an execution date of 09/02/2025 and a filing signature dated 09/04/2025 by an attorney-in-fact. No options or other derivative instruments are reported in this filing, and the filing type is a Form 4 for insider changes in beneficial ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Christopher Mahoney, a director of Bunge Global SA (BG), reported a purchase of 5,000 shares of the company's common stock on 08/18/2025 at a weighted average price of $81.73 per share, increasing his beneficial ownership to 7,164 shares. The filing notes the purchase was executed in multiple trades at prices ranging from $81.69 to $81.75. No derivative transactions were reported. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.19%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration

FAQ

How many Bunge Global SA (BG) SEC filings are available on StockTitan?

StockTitan tracks 159 SEC filings for Bunge Global SA (BG), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Bunge Global SA (BG)?

The most recent SEC filing for Bunge Global SA (BG) was filed on September 4, 2025.